Enhancing Access And Improving Retention In Rare Disease Trials With Home Trial Support

Clinical trials benefiting patients with musculoskeletal conditions pose a unique set of challenges. The limited mobility of trial participants, along with other co-existing health issues, makes traveling to trial sites a significant problem. Home Trial Support (HTS) provides a solution to improving participant retention and satisfaction during these rare disease studies.

MRN provides HTS services in 31 countries and has supported 142 trials while training 1,295 sites on Home Trial Support. HTS accelerates the recruitment of patients with mobility limitations by allowing healthcare professionals to conduct in-home procedures and assessments while enhancing patient safety and ensuring trial integrity. Through this study, you will learn more about the key outcomes and impact of HTS during musculoskeletal studies, and how MRN can help you improve the in-home care experience for trial participants.